Table 4:
Rule-based version | SVM-based version | |||
---|---|---|---|---|
Criterion | Recall (%) | Precision (%) | Recall (%) | Precision (%) |
ECOG status | 94.2 | 94.2 | 92.8 | 100.0 |
Estrogen receptor | 91.5 | 53.4 | 86.9 | 90.9 |
Progesterone receptor | 95.6 | 69.7 | 94.1 | 86.7 |
Human Epidermal Growth Factor Receptor 2 | 63.0 | 36.4 | 87.8 | 82.0 |
Postmenopausal | 88.0 | 72.1 | 86.9 | 84.1 |
AJCC tumor stage (T) | 84.7 | 83.8 | 95.5 | 97.9 |
AJCC nodes stage (N) | 79.6 | 82.6 | 72.7 | 95.7 |
AJCC metastasis stage (M) | 94.5 | 37.7 | 87.5 | 87.4 |
Overall (micro-average) | 84.6 | 64.4 | 90.9 | 89.7 |